INTRODUCTION

Top Abstract Introduction Materials and methods Results Discussion References

Progression into the DNA synthetic (S) phase of the mammalian cell cycle requires inactivation of the retinoblastoma protein (pRb) via its phosphorylation by cyclin-dependent kinases. This phosphorylation cancels pRb-mediated repression of the transactivation of genes whose activities are necessary for S-phase entry (52, 61). During the G₁ phase, pRb phosphorylation is initially triggered by the cyclin D-dependent kinases CDK4 and CDK6 and then followed by cyclin E-dependent CDK2 (23). The cyclin D- and E-dependent kinases have a propensity to phosphorylate distinct serine and threonine residues of pRb (10), and under normal conditions where both kinases are sequentially expressed at physiologic levels, pRb phosphorylation by cyclin E-CDK2 may depend upon the previous action of cyclin D-dependent kinases (10, 23). Inhibition of cyclin D-dependent kinases in cells containing a functional pRb protein prevents pRb phosphorylation and leads to G₁ phase arrest (4, 46), whereas cells lacking pRb function are refractory to such signals and continue to enter S phase (22, 26, 29, 33). In contrast, inhibition of cyclin E-dependent kinase activity in pRb-negative cells prevents S-phase entry (41), implying that cyclin E-CDK2 targets also non-pRb substrates whose phosphorylation is essential for G₁ exit. Overexpression of either cyclin D1 or E leads to a decrease in the duration of G₁ phase in rodent fibroblasts (40, 46) with additive effects when ectopic expression of both is enforced (49), but only D1 induction leads to rapid and immediate pRb hyperphosphorylation (48). Because the induction and assembly of the cyclin D-dependent kinases are controlled by extracellular mitogenic and integrin-dependent matrix signals (3), the ability of these enzymes to modulate pRb function ultimately helps to place the cell's commitment to enter S phase under non-cell-autonomous controls.

The stimulatory actions of the G₁ cyclins are countered by those of the CDK inhibitors (CKIs). There are two classes of CKIs, the INK4 proteins (INK4a to -d), which act specifically on cyclin D-dependent kinases, and the CIP/KIP family (p21^CIP1, p27^KIP1, and p57^KIP2), which functions more broadly to inhibit cyclin E-, A-, and B-dependent kinases as well (13, 54). The levels of p27^KIP1 in quiescent (G₀) T cells and fibroblasts are relatively high and greatly exceed that of the G₁ cyclins, but once these cells are stimulated to reenter the cycle and progress into late G₁ phase, much of the p27^KIP1 is degraded (25, 39, 43). Nonetheless, residual levels of p27^KIP1 and p21^CIP1 in continuously proliferating cells are believed to set an inhibitory threshold which active cyclin-CDK complexes are forced to overcome (54).

The three D-type cyclins, D1, D2, and D3, share many structural features and biochemical properties but exhibit distinct patterns of expression with respect to cell type and developmental stage (52). Skeletal myoblasts induced to differentiate under low mitogen conditions exhibit a marked decrease in cyclin D1 and a reciprocal rise in cyclin D3 expression, with a reversal of this pattern occurring upon exposure to the antidifferentiation agents bFGF and TGF- (47). Such observations suggest different modes of regulation for cyclins D3 and D1 but do not resolve whether the two play distinct roles in muscle differentiation. A comparative analysis of each D-type cyclin in a granulocyte differentiation system also suggested functional differences, in that cells overexpressing cyclins D2 and D3 but not D1 were unable to differentiate in granulocyte colony-stimulating factor (24). These observations could relate to the fact that cyclins D2 and D3, unlike D1, can interact with CDK2 (in addition to CDK4/6) to form active complexes (14). Although their differential regulation and unique biological effects in these cell culture-based systems imply that there may be distinct roles for each of the D-type cyclins in cellular growth and differentiation, such biological distinctions are not supported by the finding that, in D1- or D2-deficient mice, the vast majority of tissues which express more than one D-type cyclin appear to grow and develop normally, suggesting functional redundancy (15, 55, 56).

Forced expression of D-type and E cyclins in several cell types in transgenic mice has established an oncogenic or growth-promoting role for these G₁ cyclins (5, 6, 27, 50, 60). Nonetheless, a direct functional comparison of each D-type cyclin and cyclin E in a well-defined pRb-dependent system in vivo has yet to be conducted. We have relied upon the developing mouse lens to study cyclin function, as this organ system is (i) extremely simple and comprised of a single cell type, (ii) organized anatomically into an anterior layer of proliferating epithelial cells and a posterior compartment of postmitotic differentiated lens fiber cells, (iii) a stable developmental chronometer enabling a traceable account of experimentally induced alterations in growth, differentiation, and apoptosis, and (iv) dispensable, thus tolerating the genetic manipulation of pathways essential for viability. The cell cycle components operating in the lens have also been well defined by previous studies. pRb plays an exclusive role in controlling the mitotic arrest of lens fiber cells (36), and loss of pRb alone is associated with a dramatic increase of proliferation, accompanied by impaired expression of late-stage differentiation markers in these cells. In addition, the deregulation of lens cell proliferation by the loss of pRb activates a p53-dependent apoptotic program that leads to the efficient elimination of abnormally growing cells (36). Furthermore, lenses rendered null for both pRb-related proteins, p107 and p130, exhibit normal patterns of growth (unpublished observations).

G₁ cyclins and CKIs exhibit contrasting patterns of expression in the developing lens. In situ hybridization studies performed on embryonic lenses have revealed that endogenous cyclin D1 and D2 mRNAs are present in both the proliferative epithelial cells and in the postmitotic equatorial lens fiber cells, whereas cyclin E transcripts are not readily detected in normal lenses but are up-regulated in pRb-deficient lenses (17). Among the known CKIs, p57^KIP2 appears to play an important role as evidenced by the observations that its transcripts and protein levels are high in postmitotic lens fiber cells and its elimination by gene targeting results in inappropriate proliferation and apoptosis of lens fiber cells (62). The null p57^KIP2 phenotype is reminiscent of, but less dramatic than, the deregulated growth and apoptosis observed in the pRb-deficient lens (36). While these findings suggest a functional link between p57^KIP2 and pRb, the more attenuated consequences of p57^KIP2 deficiency point to additional regulators of pRb inactivation and S-phase entry in lens fiber cells in vivo. In this study, we examined the consequences of forced expression of each G₁ cyclin and its partner CDK in the mouse lens and have attempted to ascertain whether these G₁ cyclin-CDK activities are modulated by p57^KIP2.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and methods Results Discussion References

Production of transgenic mice. To generate the various transgenic constructs, full-length cDNAs of the mouse cyclins D1 to D3, cyclin E, CDK2, and CDK4 genes were inserted into the CPV-1 expression cassette (a kind gift from Paul Overbeek) between the A-crystallin promoter and the simian virus 40 splice and polyadenylation sequences (9, 21). By using standard transgenic mouse methodology, gel-purified transgenic inserts were microinjected into the pronucleus of fertilized eggs derived from B6/CBA F₁ intercrosses. B6/CBA F₁ mice (Jackson Laboratories) were also used to propagate the transgenic lines. Tail-derived genomic DNAs were assayed for the presence of the transgene by standard Southern and/or DNA slot blot procedures (51) using specific probes directed to the open reading frames of each transgene.

Protein isolation and Western immunoblot analyses. Lenses were homogenized in ice-cold 0.1 M Tris (pH 7.4), the water-soluble lens proteins were separated from water-insoluble lens membrane proteins by centrifugation at 4°C for 20 min (57), and the protein concentration was determined by the Bradford assay (Bio-Rad). The membrane pellets were resuspended in a mixture of ice-cold 0.1 M Tris (pH 8.0), 7 M urea, and 5 mM EDTA (8). Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (12.5% polyacrylamide) and electroblotted to nitrocellulose. Blots were blocked for 1 h at room temperature in phosphate-buffered saline (PBS) containing 5% milk and 0.1% Tween 20. The primary antibody incubations were carried out for 1 h with affinity-purified polyclonal antisera against either cyclin D1 or E (Santa Cruz Biotechnology, Inc.) or MIP26 or -crystallins (gifts from Joe Horwitz and Sam Zigler) or with a rat monoclonal antibody against cyclins D2 and D3 described previously (59), diluted in blocking solution, followed by either anti-rabbit or anti-rat immunoglobulin G horseradish peroxidase-conjugated antibody as the secondary antibody. Peroxidase activity was detected with enhanced chemiluminescence (Amersham).

Quantification of transgenic cyclin proteins. To generate recombinant cyclin proteins, cDNAs which included the coding region of cyclins D1, D3, or E subcloned into the pGEX vector (Pharmacia Biotech, Inc.) were transfected into Escherichia coli BL 21 DE3 cells (Novagene). After 4 h of IPTG (isopropyl--D-thiogalactopyranoside) induction, overnight cultures were sonicated, and the fusion proteins were purified by using glutathione-Sepharose 4B RediPack columns (Pharmacia Biotech, Inc.). The concentration of recombinant glutathione S-transferase (GST)-cyclin fusion proteins was determined by quantification of the intensity of the bands by Coomassie-stained SDS-PAGE using a Gel Doc 1000 apparatus (Bio-Rad) and employing recombinant cyclin D1 (gift from N. Pavletich) as the concentration standard. Fifty micrograms of total lens proteins, homogenized as described above, and a range of different amounts of recombinant cyclins were separated by SDS-12% PAGE and electroblotted to nitrocellulose. Blots were treated as described above. The intensity of the bands generated by chemiluminescence reaction developed by using ECL + Plus (Amersham Life Science) exposed in a film was determined with a Gel Doc 1000 apparatus (Bio-Rad), and the formula that fit the standard curve best was determined by using the CA-Cricket Graph III program. This formula was applied to estimate the concentrations of the different transgenic cyclin proteins.

Histological analysis and indirect IF. Samples were fixed in 10% buffered formalin and processed through paraffin embedding using standard procedures. Sections measuring 3 µm in thickness were cut parallel to the optic nerve, affixed to poly-L-lysine-coated slides, dewaxed in xylene, rehydrated through an ethanol series, and stained with hematoxylin and eosin. For indirect immunofluorescence (IF), paraffin-embedded sections were rehydrated, rinsed in PBS, and blocked in 3% bovine serum albumin in PBS at room temperature for 20 min. Affinity-purified polyclonal antisera against either cyclins D1, E, CDK4, or CDK2 (Santa Cruz Biotechnology, Inc.); p57^KIP2 (62); MIP26; -, -, or -crystallins (gifts from Sam Zigler and Joe Horwitz); or a rat monoclonal antibody against cyclin D2 or D3 (59) were diluted in 3% BSA-PBS, incubated on sections overnight at 4°C, and washed in PBS. The secondary antibody, fluorescein isothiocyanate-linked anti-rabbit or anti-rat immunoglobulin G antibody, was diluted, incubated for 1 h at room temperature, and washed in PBS. The amount of primary and secondary antibody used was titrated in order to yield quantitative information.

BrdU incorporation and TUNEL assays. Pregnant mice were injected intraperitoneally with bromodeoxyuridine (BrdU) dissolved in PBS at a dose of 100 µg/g of body weight (35). After 2 h, the embryos were processed to detect in situ BrdU incorporation into newly synthesized DNA as described previously (37). For detection of apoptosis in situ, the terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assay was performed as described previously (20) with minor modifications (37). To obtain a quantitative estimate of the rates of S-phase entry and apoptosis in the lens fiber region, BrdU- or TUNEL-positive nuclei were scored in a minimum of 20 different lens sections derived from two independent embryos. Nontransgenic lens fiber cells are always postmitotic and do not exhibit apoptotic features. The statistical analysis of the data was carried out using the Microsoft SPSS program.

	RESULTS

Top Abstract Introduction Materials and methods Results Discussion References

Formation of the ocular lens results from a series of developmental events whose well-defined nature greatly enhances the use of this organ as a model system for cell cycle analysis in vivo. Lens development begins on embryonic day 9.5 (E9.5) with the creation of the lens placode followed by its invagination and eventual formation of a hollow lens vesicle by E11.5. Next, lens vesicle cells positioned on the posterior wall withdraw from the cell cycle and actively differentiate into elongating primary lens fiber cells. By E14.5, the elongation process is complete, and the resultant structure is composed of an anterior layer of proliferating epithelial cells and a posterior compartment of postmitotic differentiated lens fibers. The continued growth of the lens ensues from the recruitment of proliferating epithelial cells to the lateral equatorial region where their growth is arrested and they differentiate into secondary lens fiber cells. For purposes of this study, it is important to note that growth is restricted to the anterior epithelial layer and that apoptosis, while occasionally observed in this anterior region, does not take place in the lens fiber cell compartment (45). Previous studies have shown that endogenous cyclin D1 and D2 mRNAs are expressed in both proliferative epithelial cells and in differentiating equatorial lens fiber cells (17). On the protein level, endogenous cyclin D2 protein expression is below the level of detection, while cyclin D1 immunoreactivity is readily detected in the sensory retina, the proliferative anterior epithelial layer of the lens, and to a lesser degree, in differentiating lens fiber cells of the equatorial region. Most importantly, cyclin D1 is not detected in the central-most postmitotic, fully differentiated lens fiber region (see below). Cyclin E, although detectable by reverse transcription-PCR, is not detected via RNA in situ hybridization or indirect IF analyses (data not shown).

Production of cyclin transgenic mice and analysis of lens fiber cell transgene expression. Several independent transgenic lines that ectopically express one of the three D-type cyclins or cyclin E in the postmitotic differentiated lens fiber cell compartment were generated with the aid of the A-crystallin promoter. This promoter has proven effective in directing the expression of many different transgenes to the lens fiber cell region exclusively, commencing on E12.5 and continuing thereafter (42). The level and regional pattern of expression of each transgene in fully formed E16.5 lenses or in lens-derived extracts were examined and compared with nontransgenic, age-matched controls. The transgenic lines selected for further study were found to express detectable levels of the transgene-encoded proteins by Western blot analysis (Fig. 1), and these levels were higher than those in their nontransgenic littermate controls (data not shown). To determine the amount of ectopic cyclins present in the lenses of transgenic mice, the intensity of Western blot-positive bands of several lines per construct was compared to that of bands generated by known amounts of recombinant cyclins (Fig. 1). This analysis allowed us to estimate that A-cyclin D1 line 9 and A-cyclin D1 line 23 had amounts of cyclin D1 of 76 and 46 ng per 50 µg of total protein extract, respectively; A-cyclin D3 line 25 and A-cyclin D3 line 20 had 100 and 400 ng of cyclin D3 per 50 µg of total protein extract, respectively, while A-cyclin E line 36 and A-cyclin E line 40 had 27 and 44 ng of cyclin E per 50 µg of total protein extract, respectively. To compare the phenotypes of cyclin D1 and cyclin E transgenic mice, the studies below were performed using A-cyclin D1 line 23 and A-cyclin E line 40, which had very similar levels of transgenic proteins (46 ng and 45 ng per 50 µg of total protein extract, respectively). Since cyclins are also expressed endogenously in the anterior epithelial layer (see above), IF was used to verify that abundant levels of each transgene-encoded product were properly directed to the lens fiber cell compartment. The results of representative IF studies of the various cyclin transgene-expressing lenses are presented in Fig. 2 (and see below). These studies showed that cyclin D3 transgene-encoded protein was evenly distributed throughout the nucleus and cytoplasm of lens fiber cells (Fig. 2E), whereas transgene-encoded cyclins D1, D2, and E exhibited more complex subcellular distribution patterns. Anti-D1 signals were detected in nuclei of the equatorial region with less abundant nuclear staining in the central lens fiber cells (Fig. 2B and C). In contrast, the intervening region showed predominantly cytoplasmic staining with only a few nuclei staining positive (Fig. 2). An identical staining pattern for the transgene-encoded cyclin D2 protein was observed (data not shown). Cyclin E was detected in nuclei within the equatorial region and in the cytoplasm of the remainder of the lens fiber cell compartment (Fig. 2I). Since all of the cyclin transgene constructs were driven by identical promoter and enhancer elements, these complex and distinct expression patterns likely reflect differences in posttranscriptional regulation.

View larger version (13K): [in this window] [in a new window]   FIG. 1.   Western blot analysis of recombinant GST-cyclin fusion proteins and total lens lysates derived from A-cyclin D1 and D3 and A-cyclin E transgenic mice as assayed with anti-cyclin D1 (lanes 1 to 7), anti-cyclin D3 (lanes 8 to 13) and anti-cyclin E (lanes 14 to 20) antibodies. The bands indicated with arrowheads correspond either to the previously reported sizes for cyclin D1 (35 kDa), cyclin D3 (33 kDa), or cyclin E (50 kDa) proteins or to the GST-cyclin fusion proteins. Lanes 1 to 4, decreasing amounts of GST-cyclin D1 fusion protein used as standard curve (200 ng [lane 1], 100 ng [lane 2], 50 ng [lane 3], and 25 ng [lane 4]). Lanes 5 to 7, transgenic cyclin D1 protein from lenses of A-cyclin D1 line 23 (lane 5), a transgenic mouse hemizygous for A-cyclin D1 line 23 and A-cdk4 line 14 transgenes (lane 6), and A-cyclin D1 line 9 (lane 7). Lanes 8 to 13, decreasing amounts of GST-cyclin D3 fusion protein used as standard curve (100 ng [lane 8], 50 ng [lane 9], 25 ng [lane 10], and 10 ng [lane 11]). Lanes 12 and 13, transgenic cyclin D3 protein from lenses of A-cyclin D3 line 25 (lane 12) and A-cyclin D3 line 20 (lane 13). Lanes 14 to 17, decreasing amounts of GST-cyclin E fusion protein used as standard curve (100 ng [lane 14], 50 ng [lane 15], 25 ng [lane 16], and 10 ng [lane 17]). Lanes 18 to 20, transgenic cyclin E protein from lenses of A-cyclin E line 36 (lane 18), A-cyclin E line 40 (lane 19), and a transgenic mouse hemizygous for A-cyclin E line 40 and A-cdk2 line 31 transgenes (lane 20).

View larger version (154K): [in this window] [in a new window]   FIG. 2.   In situ immunofluorescence analysis of transgene-derived protein expression in the embryonic (E16.5) lenses of the various A-cyclin and A-cdk transgenic mice and their pattern of cellular proliferation as assayed by an indirect immunoperoxidase method for the detection of BrdU incorporation into newly synthesized DNA in situ. (A) Nontransgenic lens stained with anti-cyclin D1 antibody. Cyclin D1 is the only endogenous cyclin detected with the available antisera. (B) A-cyclin D1 line 23 stained with anti-cyclin D1 antibody. (C) Higher magnification of the region framed in the upper left corner of panel B. A white arrow points to a positive stained nucleus, and a black arrow indicates a negative stained nucleus. (D) BrdU incorporation in A-cyclin D1 line 23. Arrows point to positive nuclear-associated staining indicating physiological S-phase entry in the anterior epithelial layer. (E) A-cyclin D3 line 25 stained with anti-cyclin D3 antibody. (F) BrdU incorporation pattern in A-cyclin D3 line 25. Single arrows point to normal S-phase activity in the anterior epithelial layer, while double-headed arrows point to a subset of ectopic cycling in the lens fiber compartment. (G) A-cdk4 line 14 stained with anti-CDK4 antibody. (H) BrdU incorporation pattern in A-cdk4 line 14. (I) A-cyclin E line 40 stained with anti-cyclin E antibody. (J) BrdU incorporation pattern in A-cyclin E line 40. (K) A-cdk2 line 31 stained with anti-CDK2 antibody. (L) BrdU incorporation pattern in A-cdk2 line 31. Abbreviations: e, anterior epithelial layer; f, lens fiber cells; r, retina.

Analysis of forced expression of D-type cyclins and cyclin E in the lens and its effect on cell morphology, S-phase entry, and apoptosis. Unlike nontransgenic lenses in which the lens fiber cells are arrayed along a well-defined axis, E16.5 lenses from all three A-D3 transgenic lines exhibited a severely disorganized pattern. These morphological abnormalities (apparent even in the IF studies [compare Fig. 2E with the more organized lens shown in panel G]) were consistent with altered patterns of proliferation and apoptosis (see below). In contrast, the other A-cyclin transgenic lenses (D1, D2, and E) presented with lens fiber cell compartments that were morphologically indistinguishable from nontransgenic controls (data not shown). These findings prompted a thorough analysis of patterns of growth, apoptosis, and differentiation markers in each of the transgenic lines.

View larger version (52K): [in this window] [in a new window]   FIG. 3.   Analysis of apoptosis and stage-specific differentiation markers in the embryonic lenses of G1 cyclin transgenic and control mice. Lettered panels, results of TUNEL assay of E16.5 eye sections from nontransgenic mice (A) and from A-cyclin D1, D2, E, or D3 and A-cdk4 transgenic lines (B to F, respectively). e, anterior epithelial layer; f, lens fiber cells; r, retina. Arrows indicate TUNEL-positive nuclear staining consistent with apoptotic internucleosomal cleavage. Bottom panels, Western blot analyses of early (-crystallin)- and late (MIP26)-stage differentiation markers. Each lane contains soluble lysate fraction (-crystallin) or membrane fraction derived from a lens equivalent which permits an internal comparison between -crystallin and MIP26 levels as described previously. The upper blot was probed with a rabbit polyclonal anti--crystallin antibody and the lower blot was probed with anti-MIP26 antibody. Lanes: 1, nontransgenic lens; 2, A-cyclin D1 line 23; 3, A-cyclin D2 line 2; 4, 5, and 6, A-cyclin D3 lines 20, 25, and 42, respectively; 7 and 8, A-cyclin E lines 40 and 36, respectively.

Forced expression of CDK4 or CDK2 does not promote S-phase entry. Since the G₁ cyclins form active holenzymes by assembling with CDK subunits, it was important to address whether abundant levels of these catalytic units alone, as opposed to the regulatory cyclin subunits, could promote S-phase entry. To this end, high-levels of CDK4 or CDK2 were directed to the lens fiber cell compartment with the aid of the A-crystallin promoter. IF analyses revealed that transgenic CDK4 was evenly distributed in the cytoplasm and nuclei of all lens fiber cells (Fig. 2G). In contrast, transgene-encoded CDK2 localized primarily to the cytoplasm with only a subset of equatorial and posterior cell nuclei staining positive (Fig. 2K). In the nontransgenic lens, endogenous CDK4 exhibited a diffuse pattern of subcellular distribution similar to that of the transgene-encoded protein, albeit at much lower levels, whereas endogenous CDK2 was localized to the cytoplasm of the lens fiber cells only (data not shown). Despite a clear increase in the level of transgene-encoded CDK4 and CDK2 above endogenous levels, these transgenic lenses failed to show BrdU incorporation in the lens fiber cells, indicating that a high level of CDK4 or CDK2 expression is not sufficient to promote S-phase entry (Fig. 2H and L). Unexpectedly, despite a lack of ectopic proliferation, CDK4 transgenic lines exhibited lens fiber cell apoptosis (Fig. 3F), indicating that inappropriate proliferation is not a requirement for activation of an apoptotic response. This response appears to be specific to CDK4, since apoptosis was not detected in the A-CDK2 transgenic lines even under circumstances where CDK2 was directed to the nucleus (see below).

CDK-induced nuclear translocation of cyclins D1, D2, and E promotes S-phase entry with D1/CDK4 and D2/CDK4 but not E/CDK2. The failure of transgenic cyclins D1, D2, and E to induce S-phase entry could relate, in part, to low nuclear cyclin levels that are insufficient to counter suppression by CDK inhibitors or to low partner CDK levels (see below). To address the latter, each cyclin was coexpressed along with its partner CDK through the production of double transgenics by crossing mice carrying single transgenes. Western blot analysis of lenses from transgenic mice hemizygous for A-cyclin D1 line 23 and A-cdk4 line 14 transgenes or A-cyclin E line 40 and A-cdk2 line 31 transgenes showed no significant difference in the levels of transgenic cyclin proteins compared to the respective single transgenic lines (Fig. 1). Upon quantification, these levels were 46 and 44 ng per 50 µg of protein for A-cyclin D1 line 23 and the hemizygous D1/CDK4, respectively. In the case of A-cyclin E line 40 and the hemizygous E/CDK2, the levels were 44 and 46 ng of cyclin E per 50 µg of total protein extract, respectively. Strikingly, lenses derived from mice hemizygous for both A-D1 and A-CDK4 transgenes showed a significant shift in D1 levels from the cytoplasm to nucleus in many lens fiber cells (Fig. 4A and B). To monitor the actual increase in nuclear D1 levels, the endogenous cyclin D1 levels present in the sensory retina nuclei served as an internal control (not shown). Most significantly, the increase in nuclear cyclin D1 levels was associated with S-phase entry as evidenced by the presence of BrdU-positive nuclei (Fig. 4C; Table 1). Similar results were obtained with the combination D2/CDK4 (not shown). In sharp contrast, despite an equally marked cytoplasmic-to-nuclear shift in the E/CDK2 double transgenics (Fig. 4D and E), only a few fiber nuclei stained weakly positive for BrdU incorporation. Moreover, these BrdU-positive nuclei were unusual in that they were all located in very close physical proximity to the major proliferative zone of the anterior epithelial layer (Fig. 4F; see also Discussion).

View larger version (110K): [in this window] [in a new window]   FIG. 4.   Functional interactions among cyclins D1 or E and their respective catalytic subunits, CDK4 or CDK2, and their impact on growth in E16.5 lens sections. (A) Same as panel B in Fig. 2 (A-cyclin D1 line 23 stained with anti-cyclin D1 antibody). (B and C) Lens derived from a transgenic mouse hemizygous for A-cyclin D1 line 23 and A-cdk4 line 14 transgenes stained with anti-cyclin D1 antibody (B) and its pattern of BrdU incorporation (C). Abbreviations: e, anterior epithelial layer; f, lens fiber cells. (D) Same as panel I in Fig. 2 (A-cyclin E line 40 stained with anti-cyclin E antibody). (E and F) Lens derived from a transgenic mouse hemizygous for A-cyclin E line 40 and A-cdk2 line 31 transgenes stained with anti-cyclin E antibody (E) and its pattern of BrdU incorporation (F). Single arrows point to appropriate S-phase activity in the anterior epithelial layer, while double-headed arrows point to ectopic cycling in the lens fiber compartment.

Functional cooperation between D1/CDK4 and E/CDK2. Cell culture experiments have shown that cyclins D1 and E act synergistically to decrease the duration of G₁ in rodent fibroblasts when both are co-overexpressed (49). In order to assess whether functional cooperation exists in vivo, the degrees of proliferation and apoptosis in lenses expressing various combinations of transgene-encoded cyclin D1, cyclin E, CDK4 and CDK2 were compared. Coexpression of all four transgenes (D1/CDK4/E/CDK2) promoted the highest degree of cellular proliferation (Fig. 5A and Table 1). Most significant was the fact that the D1/CDK4/E/CDK2 proliferative response exceeded that obtained when one or more of these four transgenes was not present (Table 1). For example, transgenic lenses expressing E/CDK4/CDK2 showed an average of 12 ± 1.6 positive nuclei per lens section versus 23 ± 3.2 for all four transgenes (P < 0.0001) (Fig. 5C and Table 1). Such a result underscores the importance of ectopic D1 but also suggests that low levels of endogenous cyclin D1 (present in the equatorial region) may be sufficient to activate CDK4 in these transgenic lenses. When all of the various transgenic combinations are compared, CDK4 also appears to play a very important role, since, in its absence, D1/E transgenic lenses show no S-phase entry (data not shown), and D1/E/CDK2 transgenic lenses had only 3.4 ± 0.7 BrdU-positive nuclei versus 23 ± 3.2 for all four transgenes (P < 0.0001) (Fig. 5B and Table 1). On the surface, this result suggests that cyclin D1 does not play a key role. However, it is worth noting that all of the BrdU-positive nuclei in the E/CDK2/CDK4 lens fiber region are again located in very close physical proximity to the major proliferative zone of the anterior epithelial layer, and we speculate that the anterior position of these BrdU-positive nuclei could be due to the presence of diffusible growth factors that normally serve to stimulate proliferation in the anterior epithelial compartment (Fig. 5B). Furthermore, CDK4/E compound transgenic lenses also possessed an average of 6.1 ± 1.7 positive nuclei/lens section (Fig. 5D and Table 1). This degree of S-phase entry likely reflects cooperative interactions with low endogenous levels of D1 and CDK2. In fact, some nuclear cyclin D1 expression was detected in E/CDK2/CDK4 and CDK4/E lenses in the region where the BrdU incorporation occurred (data not shown).

View larger version (62K): [in this window] [in a new window]   FIG. 5.   Functional cooperation between D1/CDK4 and E/CDK2 in the developing lens. (A to D) BrdU incorporation pattern in lenses derived from transgenic mouse A-cyclin D1 line 23, A-cdk4 line 14, A-cyclin E line 40, and A-cdk2 line 31 (A); A-cyclin D1 line 23, A-cyclin E line 40, and A-cdk2 line 31 (B); A-cdk4 line 14, A-cyclin E line 40, and A-cdk2 line 31 (C); and A-cdk4 line 14 and A-cyclin E line 40 (D). (E to H) Results of TUNEL assay in lenses derived from transgenic mouse A-cyclin D1 line 23, A-cdk4 line 14, A-cyclin E line 40, and A-cdk2 line 31 (E); A-cyclin D1 line 23, A-cyclin E line 40, and A-cdk2 line 31 (F); A-cdk4 line 14, A-cyclin E line 40, and A-cdk2 line 31 (G); and A-cdk4 line 14 and A-cyclin E line 40 (H). Arrows point to nuclei testing positive by either BrdU incorporation or TUNEL assay in the lens fiber compartment.

Role of the p57^KIP2 inhibitor in early lens formation and its functional relationship to the G₁ cyclins in the fully formed lens. We have demonstrated that p57^KIP2 levels are dramatically up-regulated in the equatorial region of the E14.5 lens, a region where epithelial cells undergo cell cycle arrest and differentiate into secondary lens fiber cells (62). Through gene targeting, we also established that high p57^KIP2 levels facilitate secondary lens fiber cell growth arrest since loss of p57^KIP2 function resulted in inappropriate S-phase entry (62). Here, we investigated two additional aspects of p57^KIP2 function: (i) its role in regulating lens cell growth arrest and initiation of primary lens fiber cell differentiation in early lens development and (ii) its functional relationship to G₁ cyclin/CDK activity in the fully formed lens.

View larger version (82K): [in this window] [in a new window]   FIG. 6.   Impaired lens fiber cells elongation in early development in the p57KIP2 null mouse. Hematoxylin and eosin (H&E) staining of E12.5 lens sections of a p57KIP2 null mouse (A) and of a wild-type mouse (B). In situ IF analysis of p57KIP2 protein expression in the embryonic (E12.5) lenses of a p57KIP2 null mouse (C) and of a wild-type mouse (D). BrdU incorporation pattern in lenses of a p57KIP2 null mouse (E) and of a wild-type mouse (F).

/

/

View larger version (98K): [in this window] [in a new window]   FIG. 7.   Functional interactions between D-type cyclins and p57KIP2. Hematoxylin and eosin (H&E) staining of E13.5 lens sections of a p57KIP2 null mouse (A), a A-cyclin D3 line 25/p57KIP2 null mouse (D), and a pRb null mouse (G). BrdU incorporation pattern in lenses of a p57KIP2 null mouse (B), a A-cyclin D3 line 25/p57KIP2 null mouse (E), a pRb null mouse (H), a A-cyclin D1 line 23/p57KIP2 null mouse (J), and a A-cyclin E line 40/p57KIP2 null mouse (K). TUNEL (TUN.) assay in lenses of a p57KIP2 null mouse (C), a A-cyclin D3 line 25/p57KIP2 null mouse (F), and a pRb null mouse (I). Arrows point to nuclei testing positive by either BrdU incorporation or TUNEL assay in the lens fiber compartment.

View this table: [in this window] [in a new window]   TABLE 2.   Average number of positive nuclei per lens ± standard deviation in E13.5 transgenic, pRb, and/or p57KIP2-deficient embryos

	DISCUSSION

Top Abstract Introduction Materials and methods Results Discussion References

Functional cooperation between cyclin D- and E-dependent kinases in vivo. This study provides a comprehensive in vivo analysis of the growth, differentiation, and apoptotic properties of each of the G₁ cyclins, their CDKs, and p57^KIP2 inhibitor in a cell type whose G₁/S transition is dependent upon pRb. Through the production and characterization of compound transgenic/knockout mice, this study also provides insight into the functional interrelationships among these regulatory molecules. Ectopic expression of the D-type cyclins, but not cyclin E, was capable of efficiently promoting G₁ exit in normally postmitotic lens fiber cells. Because we compared cyclin D1 and cyclin E transgenic lines with very similar amounts of ectopic protein (46 and 45 ng per 50 µg of total protein extract, respectively), it is unlikely that the differential phenotype was merely due to levels of expression rather than to distinct biological characteristics of these two cyclins in this setting. Among the three D-type cyclins, cyclin D3 promoted S-phase entry by itself while cyclins D1 and D2 required coexpression of ectopic CDK4. In this case, there was a significant difference in the overall levels of transgenic proteins between cyclin D1 and D3 (46 to 76 ng versus 400 to 900 ng per 50 µg of total protein extract, respectively). However, based on IF studies of these transgenic lenses, we believe that the distinction between D1 and D2 versus D3 relates more to the poor nuclear localization of the former two in the absence of CDK4. This impression is based on the observation that once adequate nuclear levels of cyclin D1 or D2 are achieved through CDK4 coexpression, the rate of proliferation appears similar to that achieved with ectopic D3 expression. In addition, upon elimination of p57^KIP2, cyclin D1 expression is capable of promoting entry into S phase. However, it remains possible that cyclin D3 may have distinct functional properties as well (e.g., the ability to more efficiently activate CDK2). This issue is difficult to address more rigorously on the biochemical level due to the small size of the embryonic mouse lens.

Subcellular distribution of the G₁ cyclins in relation to CDK coexpression. An unanticipated finding in the lens studies was the dramatic shift in subcellular distribution for D1, D2, or E upon coexpression of its partner CDK. This observed shift indicates that alterations in the levels of the G₁ CDK subunits can influence the subcellular localization of their cyclin partners in vivo. The mechanisms underlying these effects remain unclear, but coexpression of cyclins and CDKs is not likely to be sufficient for their nuclear localization as evidenced by the finding that cyclin D1 was excluded from a subset of lens fiber nuclei despite high levels of ectopic CDK4 expression in these cells in the D1/CDK4 lenses. Previous reports have described cell-cycle-dependent changes in the subcellular localization of cyclin D1 in proliferating fibroblasts, with D1 progressively accumulating in the nuclei during G₁ phase and excluded during S phase (4, 28), even though high levels of enzyme activity persist (31, 34). Cyclin E is also excluded from the nucleus in late S phase unless it is overexpressed (41), and this subcellular compartmentalization of the E/CDK2 complex appears to be an important determinant of its kinase activity (7). Hence, the nuclear targeting of cyclins D1 and D2 or cyclin E must involve regulatory mechanisms that extend beyond abundant CDK4 or CDK2 levels.

CDK4-induced apoptosis does not require S-phase progression. The results presented here show that overexpression of CDK4 can induce apoptosis in the absence of proliferation. Moreover, despite the presence of BrdU-positive nuclei in the D1/E/CDK2 lenses, no apoptotic nuclei were detected in many lenses examined. Together, these two results indicate that ectopic CDK4 plays a critical proapoptotic role. The activation of apoptosis under G₀/G₁ block is not without precedent and has been reported following Wilms tumor suppressor gene (WT1) overexpression in myeloblastic leukemia M1 cells, calcium ionophore treatment in TSU-pr1 androgen-independent prostatic cancer cells, and induction of differentiation in HL-60 cells (18, 38, 58). To place into context the activation of apoptosis by ectopic CDK4, we need to consider the status of endogenous CDKs in the embryonic lens; among these kinases, CDK5 might be highly relevant. First, CDK5 and its activating subunit p35 are highly expressed in lens fiber cells of rats at E16.5, and a shift to nuclear staining is observed immediately prior to nuclear degradation (19). Moreover, immunoprecipitates of CDK5 from lens fibers showed kinase activity in vitro with histone H1 as a substrate, suggesting a role of p35/CDK5 in differentiating lens fiber cells in addition to its reported function in neurons (19). Second, both CDK4 and p35/CDK5 have each been associated with apoptosis previously; a dominant negative of CDK4 promotes survival of nerve growth factor-deprived sympathetic neurons (44), and double labeling of p35/CDK5 and confocal microscopy detected this kinase complex in both adult and embryonic dying cells (1). In the lens system, one is tempted to speculate that the ectopic expression of CDK4 titrates away endogenous cyclin D1 which normally binds to and inhibits the p35/CDK5 complex, resulting in an indirect activation of CDK5 triggering apoptosis with no effect in proliferation.

Functional relationship between the G₁ cyclins and p57^KIP2 in vivo. The loss of pRb function results in a high rate of ectopic mitotic activity and apoptosis in the lens fiber compartment of the developing mouse (36). We have reported that loss of p57^KIP2 also leads to lens cell fiber proliferation and apoptosis, albeit to a degree that is far less pronounced than that observed in the pRb null lens (62). The more attenuated phenotype of the p57^KIP2 null lens is very similar to that of transgenic lenses overexpressing cyclin D described here. Nonetheless, in the p57^KIP2 null lens, a very high rate of proliferation (equivalent to the pRb null condition) is observed in the equatorial region where endogenous cyclin D1 and CDK4 normally persist (62). Here, D-type cyclin overexpression in a p57^KIP2 null background resulted in a degree of abnormal proliferation and apoptosis that was equivalent to that brought about by the loss of pRb. In contrast, overexpression of cyclin E in this setting had no effect on either proliferation or apoptosis. Together, these observations indicate that a multilevel regulatory circuit exists to govern the pRb-regulated G₁/S transition in lens fiber cells in vivo and that a balance between proliferation and cell cycle exit is achieved primarily through the opposing forces of activating D-type cyclin kinases and inhibitory p57^KIP2.